InsideArbitrage Event Driven Monitor – October 9, 2026

Note: You can click on any section title to jump straight to the related tool or page.

Merger Arbitrage

1. PCRX: The acquisition of Pacira BioSciences, Inc. (PCRX) by Viatris Inc. (VTRS) for a closing value of $1.65 billion. Viatris will commence a tender offer to acquire all of the outstanding shares of Pacira’s common stock for $36.50 per share in cash, representing a premium of 44.84% over the stock’s last close. (Press Release)
2. NATL: The Brink’s Co (BCO) announced that the United Kingdom’s Competition and Markets Authority (CMA) has accepted in principle Brink’s proposed remedy for its acquisition of NCR Atleos (NATL). Brink’s has been working constructively with the CMA to establish that the divestiture of NoteMachine/TestLink UK is an acceptable remedy to address the UK-specific concerns that the CMA shared with Brink’s early in the review process.
3. ACVA: Copart (CPRT) announced that it has further extended the expiration date of its all-cash tender offer to purchase ACV Auctions (ACVA) to October 15, 2026, from October 7, 2026. Computershare Trust advised Copart that approximately 90.2 million shares have been validly tendered, representing about 52.84% of the outstanding shares.

Only plus or premium subscribers can access this post. Subscribe today.